To test whether this mechanism could indeed amplify the antitumor immune response, we pretreated DLBCL cells with SUMOi and IFN-γ to maximally induce the MHC-I/APM pathway. The gene discussed is ANPEP; the disease is diffuse large B-cell lymphoma.